Asthma

The Bidirectional Nature of Asthma and Obstructive Sleep Apnea

By

Tori Rodriquez, MA, LPC, AHC

Obstructive sleep apnea was positively associated with worse outcomes in patients hospitalized because of asthma exacerbations, including increased costs, longer lengths of stay, and the need for invasive respiratory therapy.

Exacerbation-Prone Asthma: How Much Can Race, Ancestry Affect Patients?

By

Tori Rodriguez, MA, LPC, AHC

Black patients appear to have a higher risk for exacerbation-prone asthma.

Inhaler Misuse in Asthma and COPD: Undoing 40 Years of Incorrect Technique

By

Tori Rodriguez, MA, LPC, AHC

Challenges pertaining to the correct use of inhalers for asthma and COPD can limit the effectiveness of treatment.

Biologic Agents Reduce Exacerbation Rates in Severe Allergic Asthma

By

Bryant Moeller

Patients with uncontrolled severe allergic asthma who received the biologic agents benralizumab, dupilumab, or omalizumab experienced lower asthma exacerbation rates.

Evidence of Co-Occurrence, Coaggregation of Asthma, Type 1 Diabetes in Children

Children with asthma and their siblings may have an increased subsequent risk for type 1 diabetes.

FDA Strengthens Warning About Risk of Neuropsychiatric Events With Montelukast

By

Diana Ernst, RPh

The FDA recommends that montelukast only be used for allergic rhinitis in patients who have had an inadequate response or intolerance to alternative therapies.

Mepolizumab Add-On Therapy Is Effective, Safe for Severe Eosinophilic Asthma

By

Sheila Jacobs

The use of mepolizumab add-on therapy demonstrated efficacy and safety in a real-world cohort of patients with severe eosinophilic asthma.

Fixed-Dose SC Reslizumab Does Not Reduce Exacerbations in Uncontrolled Asthma

By

Pulmonology Advisor Contributing Writer

Fixed-dose subcutaneous reslizumab did not effectively reduce exacerbation frequency in patients with both uncontrolled asthma and increased blood eosinophil count.